Longitudinal change in 99mTcHMPAO cerebral perfusion SPECT in Parkinson's disease over one year

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 76, Issue 10, 2005, Pages 1448-1451

  Firbank, Michael J ^a,b   Molloy, S ^b   McKeith, I G ^a   Burn, D J ^b   O'Brien, J T ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; DIAGNOSTIC AGENT; HEXAMETHYLPROPYLENEAMINE OXIME; OXIME; RADIOPHARMACEUTICAL AGENT;

AGED; ARTICLE; BRAIN PERFUSION; BRAIN REGION; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; HUMAN; LONGITUDINAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TIME; BRAIN; BRAIN CIRCULATION; COGNITIVE DEFECT; FOLLOW UP; METABOLISM; NEUROPSYCHOLOGICAL TEST;

AGED; BRAIN; CEREBELLUM; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; FRONTAL LOBE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; OXIMES; PARKINSON DISEASE; RADIOPHARMACEUTICALS;

EID: 25444489847     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2004.058685     Document Type: Article

References (25)

1. Spampinato U, Habert MO, Mas JL, et al. (99mTc) HMPAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry 1991;54:787-92.
2. Sawada H, Udaka F, Kameyama M, et al. SPECT findings in Parkinson's disease associated with dementia. J Neurol Neurosurg Psychiatry 1992;55:960-3.
3. Markus HS, Costa DC, Lees AJ. HMPAO SPECT in Parkinson's disease before and after levodopa: correlation with dopaminergic responsiveness. J Neurol Neurosurg Psychiatry 1994;57:180-5.
4. Tachibana H, Tomino Y, Kawabata K, et al. Twelve month follow-up study of regional cerebral blood flow in Parkinson's disease. Dementia 1995;6:89-93.
5. Antonini A, de Notaris R, Benti R, et al. Perfusion ECD/SPECT in the characterisation of cognitive deficits in Parkinson's disease. Neurol Sci 2001;22:45-6.
6. Jagust WJ, Reed BR, Martin EM, et al. Cognitive function and regional cerebral blood flow in Parkinson's disease. Brain 1992;115:521-37.
7. Imon Y, Matsuda H, Ogawa M, et al. SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease. J Nucl Med 1999;40:1583-9.
8. Kikuchi A, Takeda A, Kimpara T, et al. Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease. J Neurol Sci 2001;193:29-36.
9. Abe Y, Kachi T, Kato T, et al. Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry 2003;74:419-22.
10. van Laere K, Santens P, Bosman T, et al. Statistical parametric mapping of 99mTc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters. J Nucl Med 2004;45:933-42.
11. Aarsland D, Andersen K, Larsen JP, et al. Risk of dementia in Parkinson's disease - a community-based, prospective study. Neurology 2001;56:730-6.
12. Firbank MJ, Colloby SJ, Burn DJ, et al. Regional cerebral blood flow in Parkinson's with and without dementia. Neuroimage 2003;20:1309-19.
13. Taylor AE, Saint-Cyr JA, Lang AE. Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow. Brain 1986;109:845-83.
14. Azuma T, Cruz RF, Bayles KA, et al. A longitudinal study of neuropsychological change in individuals with Parkinson's disease. Int J Geriatr Psychiatry 2003;18:1115-20.
15. Lewis SJG, Dove A, Robbins TW, et al. Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci 2003;23:6351-6.
16. Levy G, Jacobs DM, Tang MX, et al. Memory and executive function impairment predict dementia in Parkinson's disease. Mov Disord 2002;17:1221-6.
17. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-52.
18. Folstein MF, Folstein SE, McHugh PR. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
19. Roth M, Huppert FA, Mountjoy CQ, et al. CAMDEX-R: revised Cambridge examination for mental disorders of the elderly. Cambridge, UK: Cambridge University Press, 1999.
20. Yesavage JA. Geriatric depression scale. Psychopharmacol Bull 1988;24:709-11.
21. Fahn S, Elton R, Members of the UPDRS development committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, et al, eds. Recent developments in Parkinson's disease. Florham Park; NJ: MacMillan Healthcare Information, 1987.
22. Burton EJ, McKeith IG, Burn DJ, et al. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004;127:791-800.
23. Karbe H, Kertesz A, Davis J, et al. Quantification of functional deficit in Alzheimer's disease using a computer assisted mapping program for 99mTc HMPAO SPECT. Neuroradiology 1994;36:1-6.
24. Lancaster JL, Woldorff MG, Parsons LM, et al. Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 2000;10:120-31.
25. Zgaljardic DJ, Borod JC, Foldi NS, et al. A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry. Cogn Behav Neurol 2003;16:193-210.